SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-13-004745
Filing Date
2013-11-21
Accepted
2013-11-21 09:00:21
Documents
18
Period of Report
2013-11-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_112113.htm 8-K 27761
2 EXHIBIT 99.1 exh_991.htm EX-99.1 15551
3 exh991_01.jpg GRAPHIC 64163
4 exh991_02.jpg GRAPHIC 134399
5 exh991_03.jpg GRAPHIC 68476
6 exh991_04.jpg GRAPHIC 93061
7 exh991_05.jpg GRAPHIC 119893
8 exh991_06.jpg GRAPHIC 73677
9 exh991_07.jpg GRAPHIC 97347
10 exh991_08.jpg GRAPHIC 81850
11 exh991_09.jpg GRAPHIC 97583
12 exh991_10.jpg GRAPHIC 97938
13 exh991_11.jpg GRAPHIC 102679
14 exh991_12.jpg GRAPHIC 101307
15 exh991_13.jpg GRAPHIC 121592
16 exh991_14.jpg GRAPHIC 87283
17 exh991_15.jpg GRAPHIC 90753
18 exh991_16.jpg GRAPHIC 70845
  Complete submission text file 0001171843-13-004745.txt   2117119
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 131234359
SIC: 2834 Pharmaceutical Preparations